 |
 |
 |
Care Capital Group Plc is restructuring to reflect its strategy to reposition the Group primarily as an investor in, and provider of, advanced cancer treatments.
Current investments in medical centre development projects are to be transferred to the Group's wholly owned subsidiary - The Healthcare Property Company Limited - which will continue to progress existing schemes and expand through securing new medical centre projects in the UK. This company will also provide property related support services to the wider Group.
Building on the Group's 28.75% stake in Advanced Proton Solutions (Holdings) Ltd - the company that is pioneering the use of Proton Beam Therapy in the UK and which has secured planning approval for its first London based centre off Moorgate in the City of London - CareCapital (AIM: CARE) announces the formation of Oncotherapy Resources Limited ("Oncotherapy Resources"), a Company registered in England, that will provide a managed service to early stage breast cancer patients in the UK NHS, Ireland and private treatment centres. The service will be based on exclusive access to the Xoft Axxent Electronic Brachytherapy System® ("the Xoft System"). CareCapital will own 75% of Oncotherapy Resources with the balance held equally by two companies, the principal European distributor of the XoftSystem, Pergentium Ltd, and Duncan Hynd Associates Ltd. CareCapital will have the right to acquire the 25% of Oncotherapy Resources that it does not own after four years.
Current investments in medical centre development projects are to be transferred to the Group's wholly owned subsidiary - The Healthcare Property Company Limited - which will continue to progress existing schemes and expand through securing new medical centre projects in the UK. This company will also provide property related support services to the wider Group.
Building on the Group's 28.75% stake in Advanced Proton Solutions (Holdings) Ltd - the company that is pioneering the use of Proton Beam Therapy in the UK and which has secured planning approval for its first London based centre off Moorgate in the City of London - CareCapital (AIM: CARE) announces the formation of Oncotherapy Resources Limited ("Oncotherapy Resources"), a Company registered in England, that will provide a managed service to early stage breast cancer patients in the UK NHS, Ireland and private treatment centres. The service will be based on exclusive access to the Xoft Axxent Electronic Brachytherapy System® ("the Xoft System"). CareCapital will own 75% of Oncotherapy Resources with the balance held equally by two companies, the principal European distributor of the XoftSystem, Pergentium Ltd, and Duncan Hynd Associates Ltd. CareCapital will have the right to acquire the 25% of Oncotherapy Resources that it does not own after four years.